A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants

NCT05015920 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematologic Diseases

Interventions

GENETIC: BD211 Drug Product

Sponsor

Shanghai BDgene Co., Ltd.

Collaborators

[object Object]